Tag Archives: 5year

ESMO: Merck’s Keytruda doubles 5-year survival rate for lung cancer patients

Immuno-oncology competition has mounted this year in previously untreated, metastatic non-small cell lung cancer. But Merck’s Keytruda, the first PD-1/PD-L1 on the market in the setting, has new long-term survival results that the drugmaker hopes will help bolster its position. Keytruda doubled the five-year survival rate for patients whose tumors expressed levels of biomarker PD-L1… Read More »

Partners launches expansive 5-year digital health innovation plan

Partners HealthCare on Thursday announced a new five-year technology initiative designed to drive digital innovation, improve clinical care and enhance the patient experience. WHY IT MATTERSPartners officials say the program – as part of its five-year systemwide strategy and rebranding designed to position it as “health care system of the future” – will focus on… Read More »